Skip to main navigation
Skip to search
Skip to main content
Icahn School of Medicine at Mount Sinai Home
Help & FAQ
Link opens in a new tab
Search content at Icahn School of Medicine at Mount Sinai
Home
Profiles
Research units
Publications & Research Outputs
Press/Media
Renin–angiotensin–aldosterone system inhibitors and risk of covid-19
Harmony R. Reynolds
, Samrachana Adhikari
, Claudia Pulgarin
, Andrea B. Troxel
, Eduardo Iturrate
, Stephen B. Johnson
, Anaïs Hausvater
, Jonathan D. Newman
, Jeffrey S. Berger
, Sripal Bangalore
, Stuart D. Katz
, Glenn I. Fishman
, Dennis Kunichoff
, Yu Chen
, Gbenga Ogedegbe
, Judith S. Hochman
Research output
:
Contribution to journal
›
Article
›
peer-review
894
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Renin–angiotensin–aldosterone system inhibitors and risk of covid-19'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
COVID-19
100%
Renin-angiotensin-aldosterone System
100%
Severe Disease
80%
Positive Check
60%
Medication Classes
40%
Hypertension
20%
Beta-blockers
20%
Antihypertensive Medication
20%
Thiazide Diuretics
20%
Intensive Care
20%
Untreated Patients
20%
Propensity Score Matching
20%
Angiotensin Receptor Blockers
20%
Mechanical Ventilation
20%
Calcium Channel Blockers
20%
ACE Inhibitors
20%
Previous Treatment
20%
Viral Receptor
20%
Angiotensin-converting Enzyme 2 (ACE2)
20%
Bayesian Methods
20%
History of Hypertension
20%
Severe Coronavirus Disease 2019
20%
Nursing and Health Professions
COVID-19
100%
Diseases
66%
Antihypertensive Agent
16%
Propensity Score
16%
Intensive Care
16%
Receptor
16%
Angiotensin Receptor Antagonist
16%
Dipeptidyl Carboxypeptidase Inhibitor
16%
Artificial Respiration
16%
Beta Adrenergic Receptor Blocking Agent
16%
Calcium Channel Blocking Agent
16%
Thiazide Diuretic Agent
16%
Angiotensin Converting Enzyme 2
16%
Medicine and Dentistry
COVID-19
100%
Diseases
66%
Antihypertensive Agent
16%
Intensive Care
16%
Artificial Respiration
16%
ACE Inhibitor
16%
Angiotensin Receptor Antagonist
16%
Calcium Channel Blocking Agent
16%
Beta Adrenergic Receptor Blocking Agent
16%
Propensity Score Matching
16%
Thiazide Diuretic Agent
16%
Angiotensin Converting Enzyme 2
16%
Viral Receptor
16%
Mathematics
Bayesian
100%
Propensity Score Matching
100%
Percentage Point
100%
Pharmacology, Toxicology and Pharmaceutical Science
Diseases
100%
Coronavirinae
55%
Antihypertensive Agent
11%
Receptor
11%
Thiazide Diuretic Agent
11%
Beta Adrenergic Receptor Blocking Agent
11%
Calcium Channel Blocker
11%
Dipeptidyl Carboxypeptidase Inhibitor
11%
Angiotensin Converting Enzyme 2
11%
Angiotensin Receptor Antagonist
11%